By Professor John Philip Chalmers

Journal articles

De Galan BE; Perkovic V; Ninomiya T; Pillai A; Patel A; Cass A; Neal B; Poulter N; Harrap S; Mogensen CE; Cooper M; Marre M; Williams B; Hamet P; Mancia G; Woodward M; Glasziou P; Grobbee DE; MacMahon S; Chalmers J, 2009, 'Lowering blood pressure reduces renal events in type 2 diabetes', Journal of the American Society of Nephrology, 20, pp. 883 - 892, http://dx.doi.org/10.1681/ASN.2008070667

Chalmers J; Arima H, 2009, 'Management of hypertension: Evidence from the Blood Pressure Lowering Treatment Trialists' Collaboration and from major clinical trials', Polskie Archiwum Medycyny Wewnetrznej, 119, pp. 373 - 380, http://dx.doi.org/10.20452/pamw.713

Arima H; Wang JG; Huang Y; Heeley E; Skulina C; Parsons MW; Peng B; Li Q; Su S; Tao QL; Li YC; Jiang JD; Tai LW; Zhang JL; Xu E; Cheng Y; Morgenstern LB; Chalmers J; Anderson CS, 2009, 'Significance of perihematomal edema in acute intracerebral hemorrhage: The INTERACT trial', Neurology, 73, pp. 1963 - 1968, http://dx.doi.org/10.1212/WNL.0b013e3181c55ed3

Zoungas S; Chalmers J; Patel A, 2009, 'Cardiovascular Risk in Type 2 Diabetes – Reflecting on the ADVANCE Study', European Endocrinology, 05, pp. 42 - 42, http://dx.doi.org/10.17925/ee.2009.05.00.42

Turnbull F; Arima H; Heeley E; Peiris D; Weekes A; Morgan C; Cass A; Anderson C; Patel A; Chalmers J, 2009, 'Cardiovascular risk management among female and male patients in Australian General Practice: The AusHEART study', Heart, Lung and Circulation, 18, pp. S272

Heeley E; Peiris D; Weekes A; Morgan C; Cass A; Anderson C; Patel A; Chalmers J, 2009, 'Current prescribing of Blood Pressure lowering and statin therapies in Australian general practice according to risk level using new guidelines for cardiovascular risk assessment', Heart, Lung and Circulation, 18, pp. S280

Chalmers J, 2009, 'Obituary: In memoriam of Jacques de Champlain', Journal of Hypertension, 27, pp. 1927 - 1928, http://dx.doi.org/10.1097/hjh.0b013e32833235ed

Heeley E; Peiris D; Weekes A; Cass A; Anderson C; Patel A; Chalmers J, 2009, 'Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction', Heart, Lung and Circulation, 18, pp. S280 - S281

Wu Y; Huxley R; Li L; Anna V; Xie G; Yao C; Woodward M; Li X; Chalmers J; Gao R; Kong L; Yang X, 2008, 'Prevalence, awareness, treatment, and control of hypertension in China data from the China National Nutrition and Health Survey 2002', Circulation, 118, pp. 2679 - 2686, http://dx.doi.org/10.1161/CIRCULATIONAHA.108.788166

Turnbull F; Woodward M; Neal B; Barzi F; Ninomiya T; Chalmers J; Perkovic V; Li N; MacMahon S; Agodoa L; Anderson C; Asselbergs FW; Baigent C; Black H; Brenner B; Brown M; Bulpitt C; Byington R; Collins R; Cutler J; Dahlof B; Davis B; De Zeeuw D; Dens J; Estacio R; Fagard R; Fox K; Fukui T; Hansson L; Holman R; Hunsicker L; Imai Y; Ishii M; Kanno Y; Kostis J; Kuramoto K; Lewis E; Lièvre M; Lindholm LH; Liu L; Lubsen J; Lueders S; Malacco E; Mancia G; Matsuzaki M; Ohkubo T; Ogihara T; Palmer C; Pepine C; Pfeffer M; Pitt B; Poole-Wilson P; Poulter N; Rahman M; Remme W; Remuzzi G; Rodgers A; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen J; Suzuki H; Teo K; Van Gilst WH; Viberti G; Wang J; Whelton P; Wing L; Yui Y; Yusuf S; Zanchetti A, 2008, 'Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials', European Heart Journal, 29, pp. 2669 - 2680, http://dx.doi.org/10.1093/eurheartj/ehn427

Belch J; MacCuish A; Campbell I; Cobbe S; Taylor R; Prescott R; Lee R; Bancroft J; MacEwan S; Shepherd J; Macfarlane P; Morris A; Jung R; Kelly C; Connacher A; Peden N; Jamieson A; Mathews D; Leese G; McKnight J; O'Brien I; Semple C; Petrie J; Gordon D; Pringle S; MacWalter R; Chalmers J; Chalmers J; Doig J; Fraser D; Gray S; Hawthorne V; Lewis S; McCullough D; MacLeod M; Matthews D; Newton R; Reit S; Scott M; Siann T; Smith A; Walker J, 2008, 'The prevention of progression of arterial disease and diabetes (POPADAD) trial: Factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease', BMJ, 337, pp. 1030 - 1034

Chalmers J; Cooper ME, 2008, 'UKPDS and the legacy effect', New England Journal of Medicine, 359, pp. 1618 - 1620, http://dx.doi.org/10.1056/NEJMe0807625

Patel A; MacMahon S; Chalmers J, 2008, 'Dr. Patel and colleagues reply', New England Journal of Medicine, 359, pp. 1521

Patel A; MacMahon S; Chalmers J, 2008, 'Intensive glucose control in type 2 diabetes - Reply', NEW ENGLAND JOURNAL OF MEDICINE, 359, pp. 1521 - 1521, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259631700020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Perkovic V; Verdon C; Ninomiya T; Barzi F; Cass A; Patel A; Jardine M; Gallagher M; Turnbull F; Chalmers J; Craig J; Huxley R, 2008, 'The relationship between proteinuria and coronary risk: A systematic review and meta-analysis', PLoS Medicine, 5, pp. 1486 - 1495, http://dx.doi.org/10.1371/journal.pmed.0050207

Yusuf S; Anderson C; Pogue J; Dyal L; Copland I; Schumacher H; Dagenais G; Sleight P; Ramos B; Richardson L; Murphy J; Haehl M; Hilbrich L; Svaerd R; Martin K; Murwin D; Meinicke T; Schlosser A; Schmidt G; Creek R; Distel M; Aubert B; Schmieder R; Unger T; Asmar R; Mancia G; Diaz R; Paolasso E; Piegas L; Avezum A; Cardona Munoz E; Probstfield J; Weber M; Young J; Fagard R; Jansky P; Mallion J; Mann J; Böhm M; Eber B; Karatzas NB; Keltai M; Trimarco B; Verdecchia P; Maggioni A; Verheugt FWA; Holwerda NJ; Ceremuzynski L; Budaj A; Ferreira R; Chazova I; Rydén L; Svendsen TL; Metsärinne K; Dickstein K; Fodor G; Commerford P; Redon J; Luescher TR; Oto A; Binbrek A; Parkhomenko A; Jennings G; Liu LS; Yu CM; Dans AL; Shah R; Kim JH; Chen JH; Chaithiraphan S; Cairns J; Wilhelmsen L; Chalmers J; Wittes J; Gent M; Hennekens CH; Anderson N; Yusoff K; Auger P; Bernstein V; Panju A; Anand I; Bigger JT; Linz P; Healey J; Held C; McGorrian C; Rokoss M; Villar J; Dans A; Teo K; Yusuf S; McDonald A; Schweitzer D; Cunningham J; Wagan E; Boland T; Westfall L; Gulliver N; Oliveira R, 2008, 'Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial', The Lancet, 372, pp. 1174 - 1183, http://dx.doi.org/10.1016/S0140-6736(08)61242-8

Welsh P; Lowe GDO; Chalmers J; Campbell DJ; Rumley A; Neal BC; MacMahon SW; Woodward M, 2008, 'Associations of proinflammatory cytokines with the risk of recurrent stroke', Stroke, 39, pp. 2226 - 2230, http://dx.doi.org/10.1161/STROKEAHA.107.504498

Patel A; MacMahon S; Chalmers J; Neal B; Billot L; Woodward M; Marre M; Cooper M; Glasziou P; Grobbee D; Hamet P; Harrap S; Heller S; Liu L; Mancia G; Mogensen CE; Pan C; Poulter N; Rodgers A; Williams B; Bompoint S; De Galan BE; Joshi R; Travert F, 2008, 'Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes', New England Journal of Medicine, 358, pp. 2560 - 2572, http://dx.doi.org/10.1056/NEJMoa0802987

Yusuf S; Teo KK; Pogue J; Dyal L; Copland I; Schumacher H; Dagenais G; Sleight P; Anderson C; Ramos B; Richardson L; Murphy J; Haehl M; Hilbrich L; Svaerd R; Martin K; Murwin D; Meinicke T; Schlosser A; Schmidt G; Creek R; Schumacher H; Distel M; Aubert B; Pogue J; Schmieder R; Unger T; Asmar R; Mancia G; Diaz R; Paolasso E; Piegas L; Avezum A; Cardona Munoz E; Probstfield J; Weber M; Young J; Fagard R; Jansky P; Mallion J; Mann J; Böhm M; Eber B; Karatzas NB; Keltai M; Trimarco B; Verdecchia P; Maggioni A; Verheugt FWA; Holwerda NJ; Ceremuzynski L; Budaj A; Ferreira R; Chazova I; Rydén L; Svendsen TL; Metsärinne K; Dickstein K; Fodor G; Commerford P; Redon J; Luescher TR; Oto A; Binbrek A; Parkhomenko A; Jennings G; Liu LS; Yu CM; Dans AL; Shah R; Kim JH; Chen JH; Chaithiraphan S; Cairns J; Wilhelmsen L; Chalmers J; Wittes J; Gent M; Hennekens CH; Anderson N; Yusoff K; Auger P; Bernstein V; Panju A; Anand I; Bigger JT; Linz P; Healey J; Held C; McGorrian C; Rokoss M; Villar J; Anderson C; Dans A; Yusuf S; McDonald A; Pogue J; Afzal R, 2008, 'Telmisartan, ramipril, or both in patients at high risk for vascular events', New England Journal of Medicine, 358, pp. 1547 - 1559, http://dx.doi.org/10.1056/NEJMoa0801317

Stolk RP; Van Schooneveld MJ; Cruickshank JK; Hughes AD; Stanton A; Lu J; Patel A; Thom SAMG; Grobbee DE; Vingerling JR, 2008, 'Retinal vascular lesions in patients of caucasian and asian origin with type 2 diabetes', Diabetes Care, 31, pp. 708 - 713, http://dx.doi.org/10.2337/dc07-1657

Chockalingam A; Chalmers J; Whitworth J; Erdine S; Mancia G; Mendis S; Heagerty A, 2008, 'Antalya statement of the International Society of Hypertension on the prevention of blood pressure-related diseases', Journal of Hypertension, 26, pp. 2255 - 2258, http://dx.doi.org/10.1097/HJH.0b013e32831a97ff

Chalmers J; Joshi R; Kengne AP; MacMahon S, 2008, 'Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE.', Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 26, http://dx.doi.org/10.1097/01.hjh.0000320754.38732.46

Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A, 2008, 'Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: Results from ADVANCE in context of available evidence', Journal of Hypertension, 26, http://dx.doi.org/10.1097/01.hjh.0000334074.42823.77

Chalmers J; Zanchetti A, 2008, 'Introduction: Advances in the prevention of cardiovascular disease in patients with diabetes', Journal of Hypertension, 26, http://dx.doi.org/10.1097/01.hjh.0000334071.19952.e7

Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A, 2008, 'Efficacité et tolérance de lʼassociation fixe perindopril / indapamide dans le diabète de type 2: résultats de lʼétude ADVANCE', Journal of Hypertension, 26, pp. S23 - S30, http://dx.doi.org/10.1097/01.hjh.0000334603.78628.33

Jamieson F; Chalmers J; Duncan C; Prescott RJ; Campbell IW, 2008, 'Erectile dysfunction in type 1 diabetic males', The British Journal of Diabetes & Vascular Disease, 8, pp. 232 - 234, http://dx.doi.org/10.1177/1474651408094536

Chalmers J; Hunter JE; Robertson SJ; Baird J; Martin M; Franks CI; Whately-Smith CR; Mariz S; Campbell IW, 2007, 'Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes.', Curr Med Res Opin, 23, pp. 1775 - 1781, http://dx.doi.org/10.1185/030079907x210606

Dufouil C; Godin O; Chalmers J; Mazoyer B; MacMahon S; Tzourio-Mazoyer N; Tzourio C, 2006, 'O3–04–08: Effect of white matter lesions on incidence of dementia in patients with stroke', Alzheimer's & Dementia, 2, http://dx.doi.org/10.1016/j.jalz.2006.05.221

Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B, 2005, 'Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack', Stroke, 36, pp. 2164 - 2169, http://dx.doi.org/10.1161/01.str.0000181115.59173.420

Henriksen PA; Lockman KA; Robertson SJ; Clark D; Barclay JI; Chalmers J; Campbell IW, 2004, 'Audit of cardiovascular risk assessment in type 2 diabetic patients referred for insulin therapy: A cardiological perspective', British Journal of Diabetes and Vascular Disease, 4, pp. 34 - 38, http://dx.doi.org/10.1177/14746514040040010601

Chalmers JP; Arnolda LF, 2004, 'Lowering blood pressure in 2003', Medical Journal of Australia, 180, pp. 47 - 47, http://dx.doi.org/10.5694/j.1326-5377.2004.tb05783.x

CHAPMAN N; CHALMERS J, 2003, 'The prevention of secondary stroke, cardiac outcomes and cognitive decline in patients with cerebrovascular disease: The PROGRESS trial*', Seminars in Cerebrovascular Diseases and Stroke, 3, pp. 171 - 180, http://dx.doi.org/10.1053/j.scds.2003.00.027

Chalmers J, 2002, 'The ABCD of anti-hypertensive therapy?', Journal of Hypertension, 20, pp. 615 - 616, http://dx.doi.org/10.1097/00004872-200204000-00016

MacMahon S; Rodgers A; Neal B; Woodward M; Chalmers J, 2001, 'The lowering of blood pressure after stroke - Reply', LANCET, 358, pp. 1994 - 1995, http://dx.doi.org/10.1016/S0140-6736(01)06982-3

Cates C; Upton MN; D'Ambrosio M; Cruickshank J; MacMahon S; Rodgers A; Neal B; Woodward M; Chalmers J; Fournier A; Mazouz H; Choukroun G; Andrejak M; Godefroy O; Staessen JA; Wang JG; Thijs L, 2001, 'The lowering of blood pressure after stroke [1] (multiple letters)', Lancet, 358, pp. 1993 - 1996, http://dx.doi.org/10.1016/S0140-6736(01)06978-1

Chalmers J; Chapman N, 2001, 'Challenges for the prevention of primary and secondary stroke: The importance of lowering blood pressure and total cardiovascular risk', Blood Pressure, 10, pp. 344 - 351, http://dx.doi.org/10.1080/080370501753400647

, 2001, 'Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack (Vol 358, pg 1033, 2001)', LANCET, 358, pp. 1556 - 1556, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000172055800065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

MacMahon S; Neal B; Tzourio C; Rodgers A; Woodward M; Cutler J; Anderson C; Chalmers J; Ohkubo T; Bouser MG; Davis S; Donnan G; Hansson L; Harrap S; Lees KR; Liu L; Mancia G; Omae T; Reid J; Sega R; Terent A; Warlow C; Anderson N; Bladin C; Chambers B; Gordon G; Sharpe N; Collins R; Sandercock P; Simes J; Sleight P; Brnabic A; Colman S; Francis L; Lee A; Gong L; Bousser MG; Yamaguchi T; William F; Deng Q; Hu DX; Wang W; Wu AL; Ma LY; Tao ZY; Biousse V; Berthet K; Ben Slamia L; Le Denmat C; Crespi S; Foglia G; Fujimoto C; Matsumura S; Marttala K; Pettersson M; Safwenberg M; Fenton J; McIlvenna Y; Currie R; Bartram H; Briad J; Clague A; Cleverly Y; Cosson M; Culpan A; Douglas D; Flett S; Gray B; Holloway T; Milne A; Prasad R; Ratnasabapathy Y; Santos A; Wills M; Agnew T; Chapman N; Lewis N; Mullane B, 2001, 'Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack', Lancet, 358, pp. 1033 - 1041, http://dx.doi.org/10.1016/S0140-6736(01)06178-5

Chalmers J; Cooper M; Ferrannini E; Glasziou P; Grobbee D; Hamet P; Harrap S; Liu L; MacMahon S; Mancia G; Marre M; Matthews D; Mogensen C; Neal B; Yu Pan C; Poulter N; Rodgers A; Williams B; Woodward M; Collins R; Sandercock P; Sleight P; Holman R; Fulcher G; Pollock C; Celermajer D; Watson J; Harrisberg B; Currie R; Girgis S; Jayne K; Monaghan H; Patel A; Richens A; Gray B; Milne A; Adderkin A; Bak A; Flett S; De Guise D; Jetses E; Reid J; Stolk R; Wang W; Williams F; Zou X, 2001, 'Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation', Diabetologia, 44, pp. 1118 - 1120, http://dx.doi.org/10.1007/s001250100612

Phillips JK; Goodchild AK; Dubey R; Sesiashvili E; Takeda M; Chalmers J; Pilowsky PM; Lipski J, 2001, 'Differential expression of catecholamine biosynthetic enzymes in the rat ventrolateral medulla', Journal of Comparative Neurology, 432, pp. 20 - 34, http://dx.doi.org/10.1002/cne.1086

Chalmers J; Whitworth JA, 2001, 'A half-century of Australian health and medical research', Medical Journal of Australia, 174, pp. 29 - 32, http://dx.doi.org/10.5694/j.1326-5377.2001.tb143142.x

Chalmers JP, 2001, 'Ongoing trials of angiotensin-converting enzyme inhibition: What they can tell us', American Journal of Hypertension, 14, http://dx.doi.org/10.1016/s0895-7061(01)02153-7

Chalmers J, 2001, 'Rationale and design of the advance study: A randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus', Journal of Hypertension, Supplement, 19

Allan G; Chalmers J; Duncan C; Jones IG; Campbell IW, 2001, 'Audit of mortality in type 2 diabetes mellitus', The British Journal of Diabetes & Vascular Disease, 1, pp. 52 - 54, http://dx.doi.org/10.1177/14746514010010010801

Neal B; MacMahon S; Chapman N; Cutler J; Fagard R; Whelton P; Yusuf S; Agodoa L; Baigent C; Black H; Boissel JP; Brenner B; Brown M; Bulpitt C; Byington R; Chalmers J; Collins R; Dahlof B; Davis B; Estacio R; Fox K; Hansson L; Holman R; Hunsicker L; Kostis J; Kuramoto K; Kusek J; Lees R; Lewis E; Lindholm LH; Liu L; Lubsen J; Malacco E; Mancia G; Martin I; Pepine C; Pfeffer M; Pitt B; Poole-Wilson P; Remuzzi G; Rodgers A; Ruggenenti P; Schrier R; Sever P; Sleight P; Staessen J; Teo K; Turner R; Wing L; Zanchetti A; Algert C; Woodward M, 2000, 'Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials', Lancet, 356, pp. 1955 - 1964, http://dx.doi.org/10.1016/S0140-6736(00)03307-9

Chockalingam A; Chalmers J; Lisheng L; Labarthe D; MacMahon S; Martin I; Whitworth J, 2000, 'Prevention of cardiovascular diseases in developing countries: Agenda for action, statement from a WHO-ISH meeting in Beijing-October, 1999', CVD Prevention, 3, pp. 255 - 258

Chockalingam A; Balaguer-Vintro I; Achutti A; De Luna AB; Chalmers J; Farinaro E; Lauzon R; Martin I; Papp JG; Postiglione A; Srinath Reddy K; Tse TF, 2000, 'The world heart federation's white book: Impending global pandemic of cardiovascular diseases : Challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition', Canadian Journal of Cardiology, 16, pp. 227 - 229

Chalmers J, 2000, 'Blood pressure burden: Vascular changes and cerebrovascular complications', Journal of Hypertension, Supplement, 18

Chalmers J; Neal B; MacMahon S, 2000, 'PROGRESS (Perindopril Protection Against Recurrent Stroke Study): Regional characteristics of the study population at baseline', Journal of Hypertension, Supplement, 18

Stasinopoulos T; Goodchild AK; Christie MJ; Chalmers J; Pilowsky PM, 2000, 'Delta opioid receptor immunoreactive boutons appose bulbospinal Cl neurons in the rat', NeuroReport, 11, pp. 887 - 891, http://dx.doi.org/10.1097/00001756-200003200-00045

Back to profile page